Stempoint Capital’s InflaRx IFRX Stock Holding History

Stempoint Capital’s Portfolio IFRX Stock Details IFRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-725,019	Closed	-$740K	–	67
2025 Q1	$740K	Buy	+725,019	New	+$1.37M	0.24%	47

Other funds holding IFRX

SCM

Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return

6CM

683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return

RCM

RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return

Eversept Partners New York $1.9B AUM 121.13% 1-Year Est. Return

Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return

Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Raymond James Financial St Petersburg, Florida $324B AUM 22.36% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

DCM

DAFNA Capital Management Los Angeles, California $440M AUM 109.12% 1-Year Est. Return

Stempoint Capital's IFRX Position: Q2 2025 in Review

Stempoint Capital sold out of InflaRx (IFRX) in Q2 2025, closing a stake of 725,019 shares — an estimated $740K sold.

Stempoint Capital first reported a position in IFRX in Q1 2025 and held it in 1 quarter. The position peaked at $740K in Q1 2025. 27 funds tracked by Wall St. Rank hold IFRX as of Q2 2025.

Stempoint Capital reported no remaining InflaRx position as of Q2 2025 after selling out during the quarter.
Stempoint Capital sold 725,019 InflaRx shares in Q2 2025, an estimated $740K.
Stempoint Capital first reported a position in InflaRx in Q1 2025 and held it in 1 quarter.
Stempoint Capital's InflaRx position peaked at $740K in Q1 2025.
27 funds tracked by Wall St. Rank held InflaRx as of Q2 2025.

Based on Stempoint Capital's 13F filing for Q2 2025, filed 14 Aug 2025.